Controversies in perioperative management of blood thinners in dermatologic surgery: Continue or discontinue?

Dermatologic Surgery

Volumn 30, Issue 8, 2004, Pages 1091-1094

  Alcalay, Joseph ^a,c   Alkalay, Ronen ^b  

^a ASSUTA MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c NONE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN DISEASE; CARDIOVASCULAR RISK; CHEMOSURGERY; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HEMOSTASIS; HUMAN; INTERNATIONAL STANDARD UNIT; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; SKIN SURGERY; TREATMENT INDICATION; TREATMENT PLANNING;

ANTICOAGULANTS; ASPIRIN; BLOOD LOSS, SURGICAL; HUMANS; INTRAOPERATIVE CARE; INTRAOPERATIVE COMPLICATIONS; MOHS SURGERY; PRACTICE GUIDELINES; RISK ASSESSMENT; SKIN NEOPLASMS; WARFARIN;

EID: 4344573416     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30333.x     Document Type: Article

References (22)

1. Schulman S. Care of patients receiving long-term anticoagulant therapy. N Engl J Med 2003;349:675-83.
2. Hankey GJ, Eikelboom JW. Antiplatelet drugs. Med J Aust 2003;178:568-74.
3. Alcalay J. Cutaneous surgery in patients receiving warfarin therapy. Dermatol Surg 2001;27:756-8.
4. Hirsh J, Poller L. The international normalized ratio: a guide to understanding and correcting its problems. Arch Intern Med 1994;154:282-8.
5. Kargi E, Babuccu O, Hosnuter M, et al. Complications of minor cutaneous surgery in patients under anticoagulant treatment. Aesth Plast Surg 2002;26:483-5.
6. Otley CC, Fewkes JL, Frank W, et al. Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs. Arch Dermatol 1996;132:161-6.
7. Billingley EM, Maloney ME. Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and non-steroidal anti-inflammatory agents. Dermatol Surg 1997;23:381-5.
8. Schanbacher CF, Bennett RG. Postoperative stroke after stopping warfarin for cutaneous surgery. Dermatol Surg 2000;26:785-9.
9. Murad A, Goldberg LH. Serious adverse vascular events associated with periopertive interruption of antiplatelet and anticoagulant therapy. Dermatol Surg 2002;28:992-8.
10. Kovich O, Otley CC. Perioperative management of anticoagulants and platelet inhibitors for cutaneous surgery: a survey of current practice. Dermatol Surg 2002;28:513-7.
11. Dunn AS, Turpie AGG. Perioperative management of patients receiving oral anticoagulants. Arch Intern Med 2003;163:901-8.
12. Kovich O, Otley CC. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol 2003;48:233-7.
13. Ah-Weng A, Natarjan S, Velangi S, Langtry JAA. Preoperative monitoring of warfarin in cutaneous surgery. Br J Dermatol 2003;149:386-9.
14. West SW, Otley CC, Nguyen TH, et al. Cutaneous surgeons cannot predict blood thinner status by intraoperative visual inspection. Plast Reconstr Surg 2002;110:98-103.
15. Lawrence C, Sakuntabhai A, Tiling-Grosse S. Effect of aspirin and nonsteroidal anti-inflammatory drug therapy on bleeding complications in dermatologic surgical patients. J Am Acad Dermatol 1994;31:988-92.
16. Stables G, Lawrence CM. Management of patients taking anticoagulant, aspirin, non-steroidal anti-inflammatory and other antiplatelet drugs undergoing dermatological surgery. Clin Exp Dermatol 2002;27:432-5.
17. Bartlett GR. Does aspirin affect the outcome of minor cutaneous surgery? Br J Plast Surg 1999;52:214-6.
18. Goldsmith SM, Leshin B, Owen J. Management of patients taking anticoagulants and platelet inhibitors prior to dermatologic surgery. J Dermatol Surg Oncol 1993;19:578-81.
19. Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1998;114:445S-469S.
20. Wahl MJ. Myths of dental surgery in patients receiving anticoagulant therapy. J Am Dent Assoc 2000;131:77-81.
21. Lam J, Lim J, Clark J, Knox A, Poole MD. Warfarin and cutaneous surgery: a preliminary prospective study. Br J Plast Surg 2001;54:372-3.
22. Katz J, Feldman MA, Bass EB, et al. Study of medical testing for cataract surgery team: risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 2003;110:1784-8.